These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 13072425)

  • 41. [Studies on the metabolism of salicylamide-[14C]].
    WEYGAND F; BECHER A; FELDMANN D; GROSSKINSKY OA
    Hoppe Seylers Z Physiol Chem; 1953 Jun; 292(3-5):138-49. PubMed ID: 13095954
    [No Abstract]   [Full Text] [Related]  

  • 42. [Salicylamide in chemistry and pharmacology].
    REICHERT B
    Arzneimittelforschung; 1953 May; 3(5):255-6. PubMed ID: 13081471
    [No Abstract]   [Full Text] [Related]  

  • 43. [Salicylamide].
    REIPERT R
    Dtsch Med Wochenschr; 1951 Oct; 76(42):1312. PubMed ID: 14896774
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effects of intramuscular administration of salicylamide].
    HILLER E
    Arzneimittelforschung; 1953 May; 3(5):256-8. PubMed ID: 13081472
    [No Abstract]   [Full Text] [Related]  

  • 45. [Therapy of catarrhal tonsillitis in infancy with o-hydroxybenzamide (salicylamide) associated with sodium p-aminobenzoate].
    GUASCHINO S
    Gazz Med Ital; 1953 Jan; 112(1):21-2. PubMed ID: 13060598
    [No Abstract]   [Full Text] [Related]  

  • 46. [Two cases of salicylamide allergy].
    HAMRIN B; NORDSTROM S
    Sven Lakartidn; 1952 Jul; 49(29):1865-71. PubMed ID: 13015429
    [No Abstract]   [Full Text] [Related]  

  • 47. The analgesic and antipyretic properties of some derivatives of salicylamide.
    BAVIN EM; MACRAE FJ; SEYMOUR DE; WATERHOUSE PD
    J Pharm Pharmacol; 1952 Nov; 4(11):872-8. PubMed ID: 13000663
    [No Abstract]   [Full Text] [Related]  

  • 48. [Salicylamide excretion by the human organism].
    HOFFMANN W
    Arzneimittelforschung; 1955 Dec; 5(12):723-6. PubMed ID: 13293082
    [No Abstract]   [Full Text] [Related]  

  • 49. [Study of compound CR 446 combining the salicylic ion with a synthetic resin].
    LIEVRE JA; ROUILLAC R
    Sem Med Prof Med Soc; 1957 Mar; 33(12):511-6. PubMed ID: 13432924
    [No Abstract]   [Full Text] [Related]  

  • 50. [Combined para-aminobenzoic acid and salicyl (artesan A 55) in the therapy and rheumatic diseases].
    HOLTZEM MJ
    Munch Med Wochenschr; 1956 Dec; 98(49):1698-9. PubMed ID: 13387612
    [No Abstract]   [Full Text] [Related]  

  • 51. The use of calcium succinate and acetyls-salicylic acid in the treatment of rheumatic disease.
    KENNEDY AF
    Rheumatism; 1949 Jul; 5(3):86-9. PubMed ID: 18151569
    [No Abstract]   [Full Text] [Related]  

  • 52. A study of the metabolism of C14 salicylamide in the human.
    MANDEL HG; RODWELL VW; SMITH PK
    J Pharmacol Exp Ther; 1952 Dec; 106(4):433-9. PubMed ID: 13023553
    [No Abstract]   [Full Text] [Related]  

  • 53. [Salicylic acid level in blood and its relation to blood proteins].
    GRAJNERT K
    Postep Reumatol; 1956; 2():156-67. PubMed ID: 13388939
    [No Abstract]   [Full Text] [Related]  

  • 54. [The analgesic potency of acetylsalicylic acid and salicylamide; algesiametric measurements and their results in practice].
    HOFFMANN F
    Arztl Wochensch; 1953 Jul; 8(29):698-701. PubMed ID: 13080058
    [No Abstract]   [Full Text] [Related]  

  • 55. Salicylamide and acetylsalicylic acid in recurrent urolithiasis.
    PRIEN EL; WALKER BS
    J Am Med Assoc; 1956 Feb; 160(5):355-60. PubMed ID: 13278203
    [No Abstract]   [Full Text] [Related]  

  • 56. [Combined mephenesin-salicylamide in the treatment of rheumatic disease].
    SCHIAVETTI A
    Policlinico Prat; 1958 Jun; 65(24):940-5. PubMed ID: 13567103
    [No Abstract]   [Full Text] [Related]  

  • 57. [Drugs & placebos: a work on the inefficiency of salicylamide].
    GRAU CA
    Sem Med; 1958 May; 112(18):700-1 passim. PubMed ID: 13580338
    [No Abstract]   [Full Text] [Related]  

  • 58. An assessment of salicylic acid-induced mucosal damage in vivo by measuring the metabolism of salicylamide in rabbit intestine.
    Nakamura J; Katayama M; Nishida K; Sasaki H
    Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):815-8. PubMed ID: 1611698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolism of ethyl 2-carbamoyloxybenzoate (4003/2), a prodrug of salicylic acid, carsalam and salicylamide.
    Kamal A
    Biochem Pharmacol; 1990 Oct; 40(7):1669-71. PubMed ID: 2222521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Salicylamide I. Absorption, excretion, and blood levels.
    CRAMPTON JM; VOSS E
    J Am Pharm Assoc Am Pharm Assoc; 1954 Aug; 43(8):470-3. PubMed ID: 13191992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.